*December 2022*
This video presentation features perspectives from lung cancer experts Drs Alexander Spira and Helena Yu and discusses the following:
- What is an antibody-drug conjugate?
- HER-2 positive NSCLC
- Targeting HER3 NSCLC
- TROP2-directed treatment
- Novel Agents
